In this regard, methylation index (MI) of these genes in individual patient, as well as RUNX3 methylation correlated with glioma WHO grade and higher MI, or aberrant methylation of RUNX3 indicated more aggressive tumors (Majchrzak-Celińska et al. 2015). This evidence concerns the gene RUNX3 and glioma.